Current approach to endometriosis: pathogenic and therapeutic implications

Authors

  • Paulo Victor Santos Brito Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Caroline Lavinas Lúcio da Silva Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Evelyn Genielly Camilo Bezerra Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Priscila Wolbeck Jungermann Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Paulo Vytor Cardoso Nobre Acadêmico de Medicina pela Universidade Federal de Alagoas
  • Ruane Clemente Costa d’Oliveira Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Camila Andrade Brandão Acadêmico de Medicina pela Universidade Tiradentes
  • Yasmin Vitória Sousa Gois Acadêmico de Medicina pela Universidade Tiradentes
  • Lorena da Silva Santos Acadêmico de Medicina pelo Centro Universitário de Maceió
  • Ana Carolina Dória de Melo Acadêmico de Medicina pela Universidade Tiradentes
  • Morgan da Silva Peixoto Acadêmico de Medicina pela Universidade Federal de Alagoas
  • Marcos Antônio Gomes de Oliveira Acadêmico de Medicina pelo Centro Universitário de Maceió

DOI:

https://doi.org/10.36557/2674-8169.2024v6n4p1730-1742

Keywords:

endometriosis; pathogenesis; treatment; management.

Abstract

Introduction: Endometriosis is a condition characterized by the ectopic presence of functional endometrial tissue, that is, similar to the endometrium, outside the uterine cavity. These implants can be found in various regions of the pelvis, such as the ovaries, uterosacral ligaments, pelvic peritoneum and other adjacent organs. Objective: To evaluate the pathogenesis and management of endometriosis. Methodology: This is a bibliographic review that included original articles and systematic reviews in English and Portuguese, which addressed the pathogenic and therapeutic aspects of endometriosis, published between 2012 and 2024, selected from the PubMed, Scopus and SciELO databases. After careful selection, 26 articles were chosen to compose this bibliographic review. Results: Understanding the pathogenesis of endometriosis is essential, the most recognized theory is retrograde menstruation, other theories include coelomic metaplasia and Müllerian vestiges. The inflammatory and angiogenic interaction is also significant. Management can be pharmacological or surgical, with pharmacological options ranging from anti-inflammatories, progestins to GnRH agonists. Surgical treatment, preferably laparoscopic, is beneficial for cases of infertility, but preserving ovarian function is crucial for women who wish to become pregnant. Considerations: Endometriosis presents a complex pathogenesis with several theories about its origin, including genetic influences. Management involves pharmacological and surgical options, focusing on reducing estrogen levels and controlling symptoms. Understanding these mechanisms is crucial to developing more effective therapies and improving patients' quality of life.

Downloads

Download data is not yet available.

References

Bedaiwy, M. A.; Alfaraj, S.; Yong, P.; Casper, R. Novos desenvolvimentos no tratamento médico da endometriose. Fertil. Steril. [New Developments in the Medical Treatment of Endometriosis]. 2017; 107:555–565. doi: 10.1016/j.fertnstert.2016.12.025.

Brichant, G.; Laraki, I.; Henry, L.; Munaut, C.; Nisolle, M. New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments. Int. J. Mol. Sci. 2021 Sep 28; 22(19):10498. doi: 10.3390/ijms221910498. PMID: 34638843; PMCID: PMC8508913.

Bulun, S. E.; Yilmaz, B. D.; Sison, C.; Miyazaki, K.; Bernardi, L.; Liu, S.; Kohlmeier, A.; Yin, P.; Milad, M.; Wei, J. Endometriosis. Endocr. Rev. 2019; 40:1048–1079. doi: 10.1210/er.2018-00242.

Burney, R. O.; Giudice, L. C. Patogênese e fisiopatologia da endometriose [Pathogenesis and Pathophysiology of Endometriosis]. Fertil. Steril. 2012; 98:511–519.

Deiana, D.; Gessa, S.; Anardu, M.; Daniilidis, A.; Nappi, L.; D’Alterio, M. N.; Pontis, A.; Angioni, S. Genetics of endometriosis: A comprehensive review. Gynecol. Endocrinol. 2019; 35:553–558. doi: 10.1080/09513590.2019.1588244.

Diamond, M. P.; Carr, B.; Dmowski, W. P.; Koltun, W.; O'Brien, C.; Jiang, P.; Burke, J.; Jimenez, R.; Garner, E.; Chwalisz, K. Elagolix Treatment for Endometriosis-Associated Pain: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study]. Reprod. Sci. 2014; 21:363–371. doi: 10.1177/1933719113497292.

Forster, R.; Sarginson, A.; Velichkova, A.; Hogg, C.; Dorning, A.; Horne, A. W.; Saunders, P. T. K.; Greaves, E. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis. FASEB J. 2019; 33:11210–11222. doi: 10.1096/fj.201900797R.

Gezer, A.; Oral, E. Terapia com progestina na endometriose [Progestin Therapy in Endometriosis]. Women’s Health. 2015; 11:643–652. doi: 10.2217/whe.15.42.

Gibson, D. A.; Simitsidellis, I.; Collins, F.; Saunders, P. T. K. Andrógenos, estrogênios e endométrio: Um equilíbrio delicado entre perfeição e patologia [Androgens, Estrogens, and Endometrium: A Delicate Balance Between Perfection and Pathology]. J. Endocrinol. 2020; 246:R75–R93. doi: 10.1530/JOE-20-0106.

Guo, M.; Bafligil, C.; Tapmeier, T.; Hubbard, C.; Manek, S.; Shang, C.; Martinez, F. O.; Schmidt, N.; Obendorf, M.; Hess-Stumpp, H.; et al. Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: A characterisation study. BMC Med. 2020; 18:3. doi: 10.1186/s12916-019-1470-y.

Horne, A. W.; Saunders, P. T. K.; Abokhrais, I. M.; Hogg, L.; on behalf of the UK and Ireland Endometriosis Priority Setting Partnership Steering Group. The top ten research priorities in endometriosis in the UK and Ireland. Lancet. 2017; 389:2191–2192. doi: 10.1016/S0140-6736(17)31344-2.

Konrad, L.; Dietze, R.; Riaz, M. A.; Scheiner-Bobis, G.; Behnke, J.; Horne, F.; Hoerscher, A.; Reising, C.; Meinhold-Heerlein, I. Epithelial-Mesenchymal Transition in Endometriosis-When Does It Happen? J. Clin. Med. 2020; 9:1915. doi: 10.3390/jcm9061915.

Kvaskoff, M.; Mu, F.; Terry, K. L.; Harris, H. R.; Poole, E. M.; Farland, L.; Missmer, S. A. Endometriosis: A high-risk population for major chronic diseases? Hum. Reprod. Update. 2015; 21:500–516. doi: 10.1093/humupd/dmv013.

Laganà, A. S.; Garzon, S.; Gotte, M.; Viganò, P.; Franchi, M.; Ghezzi, F.; Martin, D. C. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int. J. Mol. Sci. 2019; 20:5615. doi: 10.3390/ijms20225615.

Macer, M. L.; Taylor, H. S. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet. Gynecol. Clin. North Am. 2012 Dec; 39(4):535-549. doi: 10.1016/j.ogc.2012.10.002.

Madjid, T. H.; Jumadi; Judistiani, R. T. D.; Hernowo, B. S.; Faried, A. Detection of endometriosis using immunocytochemistry of P450 Aromatase expressions in eutopic endometrial cells obtained from menstrual sloughing: A diagnostic study. BMC Res. Notes. 2020; 13:233. doi: 10.1186/s13104-020-05070-w.

Patel, B. G.; Lenk, E. E.; Lebovic, D. I.; Shu, Y.; Yu, J.; Taylor, R. N. Pathogenesis of endometriosis: Interaction between endocrine and inflammatory pathways. Best Pract. Res. Clin. Obstet. Gynaecol. 2018; 50:50–60.

Pellicer, N.; Galliano, D.; Herraiz, S.; Bagger, Y. Z.; Arce, J.-C.; Pellicer, A. Use of dopamine agonists to target angiogenesis in women with endometriosis. Hum. Reprod. 2021; 36:850–858. doi: 10.1093/humrep/deaa337.

Quaas, A. M.; Weedin, E. A.; Hansen, K. R. Uso de medicamentos on-label e off-label no tratamento da endometriose. Fertil. Steril. [On-label and off-label medication use in the treatment of endometriosis]. 2015; 103:612–625. Doi 10.1016/j.fertnstert.2015.10.006.

Riccio, L. G. C.; Jeljeli, M.; Santulli, P.; Chouzenoux, S.; Doridot, L.; Nicco, C.; Reis, F. M.; Abrão, M. S.; Chapron, C.; Batteux, F. B lymphocyte inactivation by Ibrutinib limits endometriosis progression in mice. Hum. Reprod. 2019; 34:1225–1234. doi: 10.1093/humrep/dez071.

Rizner, T. L. Noninvasive biomarkers of endometriosis: Myth or reality? Expert Rev. Mol. Diagn. 2014; 14:365–385. doi: 10.1586/14737159.2014.899905.

Rogers, P. A.; Adamson, G. D.; Al-Jefout, M.; Becker, C. M.; D'Hooghe, T. M.; Dunselman, G. A.; Fazleabas, A.; Giudice, L. C.; Horne, A. W.; Hull, M. L.; et al. Research priorities for endometriosis. Reprod. Sci. 2017; 24:202–226. doi: 10.1177/1933719116654991.

Samani, E. N.; Mamillapalli, R.; Li, F.; Mutlu, L.; Hufnagel, D.; Krikun, G.; Taylor, H. S. Micrometastasis of endometriosis to distant organs in a murine model. Oncotarget. 2019; 10:2282–2291. doi: 10.18632/oncotarget.16889.

Saraswat, L.; Ayansina, D.; Cooper, K. G.; Bhattacharya, S.; Horne, A. W.; Bhattacharya, S. Impact of endometriosis on the risk of additional gynecological surgery and cancer: A national cohort study. BJOG. 2018; 125:64–72. doi: 10.1111/1471-0528.14793.

Wang, W.; Vilella, F.; Alama, P.; Moreno, I.; Mignardi, M.; Isakova, A.; Pan, W.; Simon, C.; Quake, S. R. Single-cell transcriptomic atlas of the human endometrium across the menstrual cycle. Nat. Med. 2020; 26:1644–1653. doi: 10.1038/s41591-020-1040-z.

Zondervan, K. T.; Becker, C. M.; Missmer, S. A. Endometriosis. N. Engl. J. Med. 2020; 382:1244–1256. doi: 10.1056/NEJMra1810764.

Published

2024-04-18

How to Cite

Victor Santos Brito, P., Lavinas Lúcio da Silva, C., Genielly Camilo Bezerra, E., Wolbeck Jungermann, P., Vytor Cardoso Nobre, P., Clemente Costa d’Oliveira , R., Andrade Brandão , C., Vitória Sousa Gois, Y., da Silva Santos , L., Carolina Dória de Melo, A., da Silva Peixoto, M., & Antônio Gomes de Oliveira , M. (2024). Current approach to endometriosis: pathogenic and therapeutic implications. Brazilian Journal of Implantology and Health Sciences, 6(4), 1730–1742. https://doi.org/10.36557/2674-8169.2024v6n4p1730-1742